Tag: lab sale

Sonic, Western Connecticut Health Network Announce New Laboratory Joint Venture

By Joseph Burns, from the Volume XXIV, No. 4 – March 13, 2017 issue

CEO SUMMARY: To prepare for the transition from fee-for-service to value-based payment, Western Connecticut Health Network, a three-hospital health system, announced a laboratory joint venture with Sonic Healthcare. Benefits will include lower test costs, more competitive prices, and the ability to offer same-day turn-around in Western Connecticut. Another benefit is that physicians in towns WCHN

View Article

LabCorp, Quest, Sonic Do Hospital Lab Deals

By Joseph Burns, from the Volume XXIV, No. 4 – March 13, 2017 issue

CEO SUMMARY: Is the New Year’s spate of deals involving the sales of hospital lab outreach programs and a new joint venture the first tremors of an impending earthquake of similar transactions? In the first 10 weeks of 2017, Laboratory Corporation of America, Quest Diagnostics, and Sonic Healthcare announced significant agreements to purchase sizeable hospital

View Article

Sale to LabCorp to End Most of PAML’s Lab JVs

By Robert Michel, from the Volume XXIV, No. 4 – March 13, 2017 issue

CEO SUMMARY: It will take several years to understand how the market for lab testing services will change in Seattle and the Pacific Northwest, once Laboratory Corporation of America becomes the owner of PAML, based in Spokane, Wash. Price and financial terms of the sale were not disclosed. The announcement of the agreement also reported

View Article

Giving Back to the Clinical Lab Profession

By R. Lewis Dark, from the Volume XXIII No. 5 - April 11, 2016 issue

MANY OF US ARE CONCERNED about how the next generation of clinical lab and anatomic pathology leaders will be trained and prepared to step up and assume responsibility for the clinical excellence and financial performance of their respective lab organizations.

To contribute to the training of promising young lab managers, in the past two years THE DARK REPORT has

View Article

Understanding the Future Of Laboratory Medicine

By Robert Michel, from the Volume XXIII No. 4 – March 21, 2016 issue

CEO SUMMARY: Healthcare’s transformation is now far enough along that most clinical labs and pathology groups are either feeling the financial pain or are excitedly developing ways to deliver more value from lab testing services. On April 26-27, at the 21st annual Executive War College on Lab and Pathology Management, expert speakers will address how

View Article

How Mentors Can Best Train Young Lab Leaders

By Robert Michel, from the Volume XXIII No. 3 – February 29, 2016 issue

CEO SUMMARY: Mentoring will be the theme of a special learning track at this year’s Executive War College. Two nationally-respected experts on mentoring and leadership development will work with participating lab mentors and mentorees to help them advance their mentoring relationship. All of this is designed to help your laboratory prepare its younger managers to

View Article

Letter to Florida Doctor Offers to Waive Lab Test Fees

By Joseph Burns, from the Volume XXII NO. 17 - December 7, 2015 issue

CEO SUMMARY: Florida’s highly-competitive market for lab testing services is again seeing some lab companies use “Waiver of Charges to Managed Care Patients” agreements with physicians in situations where the lab is an out-of-network provider. This means the lab will do free testing—waiving charges to the health plan and the patient—in order to keep the

View Article

New Developments in $1 Billion Lab Fraud Case

By R. Lewis Dark, from the Volume XXII NO. 13 - September 14, 2015 issue

CEO SUMMARY: Court documents filed last month in the federal qui tam case against Health Diagnostic Laboratory, Singulex, Berkeley Heart Lab, BlueWave Healthcare Consultants, and several lab executives allege that the defendants used illegal inducements and kickbacks to file false claims and generate payments of $500 million from Medicare and Tricare. This money was paid in just 60 months, from 2010 through 2014. Add up payments to the defendants from private insurers-two of whom are suing HDL-and the total could be as much as $1.2 billion.

View Article

Winning Bidder for HDL Connected to BlueWave

By Joseph Burns, from the Volume XXII NO. 13 - September 14, 2015 issue

CEO SUMMARY: Events within the bankruptcy proceedings of Health Diagnostic Laboratory could be interpreted as setting the stage for the emergence of a laboratory company operated by executives-and marketed by a sales consultant-known to have had leadership roles in other lab companies accused by whistleblowers and the federal government of making illegal payments to induce physicians to refer lab tests to their respective lab companies. In that regard, some in the lab industry may consider this an example of history about to repeat itself.

View Article

New Developments in $1 Billion Laboratory Fraud Case

By Mary Van Doren

IT’S THE $1 BILLION LABORATORY FRAUD that no one realized had grown so big. In this special issue of THE DARK REPORT, you’ll read how the next chapter of the federal whistleblower lawsuit against three specialty cardiology labs and certain individuals has pulled the curtain open on what we believe is the biggest case of laboratory fraud and abuse in the past 30 years.

Court documents filed

View Article

Volume XXVI No. 2 – February 4, 2019

NOW THAT MOST HOSPITALS ARE INCLUDED as applicable laboratories that must report their PAMA private payer lab test price data to the Centers for Medicare and Medicaid Services, managers of those labs will benefit from the incisive analysis in this issue of the lessons learned during the 2017 PAMA reporting cycle. THE DARK REPORT further offers recommendations on how labs can do a better job of gathering and reporting their own data to CMS. Also, TDR delivers an exclusive analysis of why the Government Accounting Office's assertion that CMS will be paying billions more for Part B clinical lab tests is simply wrong.

See the full table of contents

Tag: lab sale

Enter Your Login Credentials